With repeated administration of tocilizumab and rituximab plus the continuation of corticosteroid and supportive treatment, serum Cre showed a trend of improvement from day 19, T-bil from day 35, and platelets from day 39.
← all excerpts
A Case of Repeated TAFRO Syndrome-Like Symptoms and Retroperitoneal Hemorrhage in a Patient With Sjögren Syndrome.
1
—
—